eMedicine Specialties > Pediatrics: General Medicine > Parasitology

Dracunculiasis

Author: Vinod K Dhawan, MD, FACP, FRCP(C), Professor, Department of Clinical Medicine, University of California, Los Angeles, David Geffen School of Medicine; Professor of Medicine, Charles Drew University of Medicine and Science; Chief, Division of Infectious Diseases, MLK-Harbor Hospital
Contributor Information and Disclosures

Updated: Nov 24, 2009

Introduction

Background

Dracunculiasis is an infection caused by the nematode Dracunculus medinensis, also known as the guinea fire worm. D medinensis is in the order Spirurida, an order of parasites that includes the filariae Wuchereria bancrofti, Brugia malayi, and Loa loa. During the last 25 years, concerted efforts to eradicate the guinea worm have been undertaken and these have resulted in a reduction of more than 99% of worldwide cases of dracunculiasis.

Current disease incidence is low and is limited specifically to sub-Saharan Africa. The Centers for Disease Control and Prevention (CDC) proposed a global campaign for eradication of dracunculiasis in 1980, and, in 1988, numerous African ministers of health set a target date of 1995 for total eradication. After that target was missed due to slow mobilization in countries with endemic disease, a target date of 2009 was set. Unfortunately, despite considerable progress, that date was also not met. By the end of 2008, dracunculiasis was endemic in 6 countries (Ethiopia, Ghana, Mali, Niger, Nigeria, and Sudan), and the number of cases decreased 52% (from 9,585 in 2007 to 4,619 in 2008).1 Sporadic violence and civil unrest in Sudan and Mali poses the greatest threat to the final eradication of dracunculiasis.

During ancient times, the presence of dracunculiasis can be inferred by the universally recognized symbol of medicine, the Greek asklepios (ie, Roman aesculapius), which consists of a one-headed snake wrapped around a stick. Dead female worms have also been found in Egyptian mummies older than 3000 years, and writings in ancient Sanskrit, Greek, and Hebrew refer to Dracunculus infection. To this day, the most effective method dracunculiasis treatment involves extraction by wrapping the worm around a stick, as is seen in the image below.

A method used to extract a guinea worm from the l...

A method used to extract a guinea worm from the leg vein of a human patient.

A method used to extract a guinea worm from the l...

A method used to extract a guinea worm from the leg vein of a human patient.


The term dracunculus is Latin for "little dragon," a misnomer and reference to the symbol. Thus, when the guinea worm disappears, one of the original inspirations for the discipline of medicine will also disappear. Currently, the infection persists and, although uncommon, can cause significant morbidity.

Pathophysiology

Ingestion of water that contains infective Dracunculus larvae causes the infection. The larvae reside in an intermediate host, a tiny fresh-water crustacean or copepod of the genus Cyclops. The acidic environment of the stomach and duodenum kills the copepods. The larvae are subsequently released in the stomach or small intestine and penetrate the mucosa to mate and mature in the abdomen or retroperitoneal space approximately 60-90 days after initial infection. The maturation stage can last for up to 1 year, and, during this time, the adult male probably dies because only the female worm is recovered from symptomatic patients.

After maturation is complete, the female Dracunculus reaches a length of up to 1 m (with a thickness of only 1-2 mm) and slowly migrates from the GI tract into subcutaneous tissue, usually to a location in the lower extremity. The actual route of migration is unknown. In this subcutaneous location, one or more females prepare larval exit sites through the skin, from whence larvae may be released into another water supply. Free-living larvae can survive only 3 days without a host; they become infective after 2 weeks (2 molts) within the host copepod.

Frequency

United States

Dracunculiasis is rarely imported to the United States. Two cases have been reported since 1995, both occurring in individuals from Sudan.

International

In the early 1990s, 3-5 million cases of dracunculiasis occurred worldwide each year. By 1996, only 152,805 cases were reported, most from Ghana and Sudan. Presently, only 9 countries are endemic: Sudan, Ghana, Nigeria, Mali, Togo, Burkina Faso, Ethiopia, Niger, and Ivory Coast.2 Recent statistics indicate that only 8,191 cases were reported during the first half of 2005 from these 9 nations.3 At the end of 2004, all of Asia was free of the disease. Sporadic cases have been noted in Australia and North America in African immigrants during the period 200-2005, and since 2006 only sporadic cases in African nations have been reported.

Mortality/Morbidity

Death due to dracunculiasis is not caused by the primary infection and occurs only in cases in which secondary infection of the worm's exit site leads to sepsis . The mortality rate is quite low; however, morbidity is a major concern, with secondary infection being the most common complication. Cellulitis or the formation of an abscess requires prompt attention, and pain from the exit sites often can incapacitate patients for weeks. This is usually observed in individuals who have multiple worms and rely on their ability to stand or walk for their livelihood. Farmers with untreated dracunculiasis in Nigeria have been found to miss work for up to 3 months. Infected schoolchildren may miss up to 25% of the school year. Therefore, Dracunculus infection can cause significant socioeconomic burden for individuals and communities.

Another, more chronic, complication of dracunculiasis is encapsulation of the adult worm, which occurs when the calcified remains of the worm persist in the extremity of the patient. This can result in chronic pain and intermittent swelling of the extremity. In a small percentage of individuals who have permanent scarring or deformity of the lower extremity, even after the worm has been extracted, chronic pain may persist for as long as 18 months. Notably, on average, infected individuals have multiple worm extrusions at the same time (1.8 worms per person, on average). Rarely, dracunculiasis can present with worms located in anomalous locations, including the lungs, pancreas, testes, spinal cord, or periorbital tissue.

Race

No race predilection is noted.

Sex

No sex predilection is observed.

Age

Most reported dracunculiasis cases occur in the young adult (working) population who may be exposed to contaminated water sources more frequently; however, no particular age predilection is noted.

Clinical

History

  • Travel to or residence in endemic countries is invariably part of the history in patients with dracunculiasis.
  • Recollection of ingestion of unfiltered or untreated water, ingestion of fresh fruits or vegetables washed with such water, or bathing or swimming in potentially contaminated water are all possibly elicited in the patient's history. The transmission of the disease has seasonal variation. In arid areas, the rainy season, with increased availability of surface water, coincides with most cases. In wet areas, the dry season, when sources of drinking water are limited, is associated with most cases.
  • History tends to be useful only to confirm the diagnosis after it has been presumed based on physical examination findings.

Physical

  • A blister forms in the epidermis at a site chosen by the female worm, usually in the lower extremity.
    • Immediately before blister formation, allergic-type symptoms, such as mild respiratory distress with wheezing, urticaria, periorbital edema, and pruritus, are often present.
    • Patients may also be febrile during this period.
    • With the emergence of the worm's head, the blister grows and becomes erythematous at its periphery.
    • Edema occurs around the site, and inflammation of the papule causes further pruritus and burning pain.
    • Usually, after a few days, but possibly as long as 2 weeks, the blister erupts, and the worm releases a collection of larvae-containing fluid.
    • The swelling and pain often are markedly decreased after the blister is opened.
    • At this point, an ulcer forms around the blister site as the adult worm continues to emerge.
  • Definitive diagnosis is made when the head of the worm is identified within the ulcer.
  • As noted, the ulcer tends to become secondarily infected.
  • No other particular physical findings are commonly noted, although some degree of lymphadenopathy may be found at any stage of the illness.

Causes

  • Dracunculiasis is an infection caused by the nematode D medinensis.
  • The larvae from D medinensis are not infective unless a molting process within the copepods occurs. This requires a fresh-water environment; thus, water ingestion is the only identified mode of transmission.

More on Dracunculiasis

Overview: Dracunculiasis
Differential Diagnoses & Workup: Dracunculiasis
Treatment & Medication: Dracunculiasis
Follow-up: Dracunculiasis
Multimedia: Dracunculiasis
References

References

  1. Progress toward global eradication of dracunculiasis, January 2008-June 2009. MMWR Morb Mortal Wkly Rep. Oct 16 2009;58(40):1123-5. [Medline].

  2. CDC. Progress toward global eradication of dracunculiasis, January-June 2003. MMWR Morb Mortal Wkly Rep. Sep 19 2003;52(37):881-3. [Medline].

  3. CDC. Progress toward global eradication of dracunculiasis, January 2004-July 2005. MMWR Morb Mortal Wkly Rep. Oct 28 2005;54(42):1075-7. [Medline].

  4. Adewale B, Mafe MA, Sulyman MA. Impact of guinea worm disease on agricultural productivity in Owo local government area, Ondo state. West Afr J Med. May-Jun 1997;16(2):75-9. [Medline].

  5. Behbehani K. Candidate parasitic diseases. Bull World Health Organ. 1998;76 Suppl 2:64-7. [Medline].

  6. Bimi L, Freeman AR, Eberhard ML, et al. Differentiating Dracunculus medinensis from D. insignis, by the sequence analysis of the 18S rRNA gene. Ann Trop Med Parasitol. Jul 2005;99(5):511-7. [Medline].

  7. Bloch P, Simonsen PE. Immunoepidemiology of Dracunculus medinensis infections I. Antibody responses in relation to infection status. Am J Trop Med Hyg. Dec 1998;59(6):978-84. [Medline][Full Text].

  8. Greenaway C. Dracunculiasis (guinea worm disease). CMAJ. Feb 17 2004;170(4):495-500. [Medline][Full Text].

  9. Hopkins DR, Ruiz-Tiben E, Downs P, et al. Dracunculiasis eradication: the final inch. Am J Trop Med Hyg. Oct 2005;73(4):669-75. [Medline].

  10. Hopkins DR, Ruiz-Tiben E, Ruebush TK. Dracunculiasis eradication: almost a reality. Am J Trop Med Hyg. Sep 1997;57(3):252-9. [Medline].

  11. Hunter JM. An introduction to guinea worm on the eve of its departure: dracunculiasis transmission, health effects, ecology and control. Soc Sci Med. Nov 1996;43(9):1399-425. [Medline].

  12. Levinson WE, Jawetz E. Nematodes: Dracunculiasis. In: Medical Microbiology and Immunology. 1994;285-286.

  13. Menon T. Incidental finding of Dracunculus medinensis in Australia. Med J Aust. Jul 4 2005;183(1):51-2. [Medline].

  14. MMWR Morb Mortal Wkly Rep. Imported dracunculiasis--United States, 1995 and 1997. Mar 27 1998;47(11):209-11. [Medline].

  15. Muller R. Guinea worm disease--the final chapter?. Trends Parasitol. Nov 2005;21(11):521-4. [Medline].

  16. Sam-Abbenyi A, Dama M, Graham S, Obate Z. Dracunculiasis in Cameroon at the threshold of elimination. Int J Epidemiol. Feb 1999;28(1):163-8. [Medline].

  17. [Guideline] Watts SJ. The comparative study of patterns of guinea worm prevalence as a guide to control strategies. Soc Sci Med. 1986;23(10):975-82. [Medline].

  18. WHO. Dracunculiasis (guinea-worm disease) eradication. Wkly Epidemiol Rec. Apr 16 2004;79(16):154-5. [Medline].

Further Reading

Keywords

dracunculiasis, dracontiasis, dracunculosis, guinea worm infection, Dracunculus medinensis, D medinensis, guinea fire worm, Medina worm, serpent worm, dragon worm

Contributor Information and Disclosures

Author

Vinod K Dhawan, MD, FACP, FRCP(C), Professor, Department of Clinical Medicine, University of California, Los Angeles, David Geffen School of Medicine; Professor of Medicine, Charles Drew University of Medicine and Science; Chief, Division of Infectious Diseases, MLK-Harbor Hospital
Vinod K Dhawan, MD, FACP, FRCP(C) is a member of the following medical societies: American College of Physicians, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and Royal College of Physicians and Surgeons of Canada
Disclosure: Pfizer Inc None None

Medical Editor

Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA, Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital
Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Pediatric Infectious Diseases Society, Royal Australasian College of Physicians, and Royal College of Pathologists of Australasia
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Martin Weisse, MD, Program Director, Associate Professor, Department of Pediatrics, West Virginia University
Martin Weisse, MD is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; sanofi pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.